Production (Stage)
Edgewise Therapeutics, Inc.
EWTX
$15.29
-$0.13-0.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 436.39M | 470.17M | 492.54M | 511.75M | 532.76M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.79M | 5.31M | 6.90M | 7.69M | 8.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 443.18M | 475.48M | 499.44M | 519.44M | 541.43M |
|
|
|||||
| Total Current Assets | 443.18M | 475.48M | 499.44M | 519.44M | 541.43M |
| Net Property, Plant & Equipment | 10.52M | 11.07M | 11.58M | 11.94M | 12.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 695.00K | 262.00K | 262.00K | 262.00K | -- |
| Total Assets | 454.39M | 486.82M | 511.28M | 531.65M | 553.81M |
|
|
|||||
| Total Accounts Payable | 8.79M | 5.58M | 5.65M | 6.80M | 4.72M |
| Total Accrued Expenses | 11.33M | 17.29M | 12.32M | 9.39M | 8.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.00M | 996.00K | 992.00K | 988.00K | 984.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.12M | 23.86M | 18.96M | 17.18M | 14.60M |
|
|
|||||
| Total Current Liabilities | 21.12M | 23.86M | 18.96M | 17.18M | 14.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.56M | 3.74M | 3.45M | 4.00M | 4.27M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.67M | 27.60M | 22.41M | 21.17M | 18.87M |
|
|
|||||
| Common Stock & APIC | 848.69M | 837.37M | 826.74M | 816.31M | 809.09M |
| Retained Earnings | -419.37M | -378.58M | -338.91M | -304.79M | -273.29M |
| Treasury Stock & Other | 401.00K | 420.00K | 1.05M | -1.05M | -861.00K |
| Total Common Equity | 429.72M | 459.22M | 488.88M | 510.47M | 534.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 429.72M | 459.22M | 488.88M | 510.47M | 534.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 429.72M | 459.22M | 488.88M | 510.47M | 534.94M |
|
|
|||||